上海百生跃生物科技有限公司 公司信息
公司名称:
上海百生跃生物科技有限公司
电话:
-
电子邮件:
guojing@bioleaper.com
国籍:
中国
网址:
www.bioleaper.com/
产品总数:
5615
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
公司提供产品列表
Anti-AXL / UFO Reference Antibody (mipasetamAb)
Anti-AXL / UFO Reference Antibody (ORY012)
Anti-AXL / UFO Reference Antibody (tilvestamab)
Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (adebrelimab)
Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (atezolizumab)
Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (avelumab)
Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (cosibelimab)
Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (durvalumab)
Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (garivulimab)
Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (lodapolimab)
Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (MDX-1105)
Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (opucolimab)
Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (pacmilimab)
Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (sudubrilimab)
Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (sugemalimab)
Anti-B7-H2 / ICOSL / CD275 Reference Antibody (prezalumab)
Anti-B7-H3 / CD276 Reference Antibody (enoblituzumab)
Anti-B7-H3 / CD276 Reference Antibody (mirzotamAb)
Anti-B7-H3 / CD276 Reference Antibody (omburtamab)
Anti-B7-H3 / CD276 Reference Antibody (Trellis patent anti-B7-H3)
Anti-B7-H4 / VTCN1 Reference Antibody (alsevalimab)
Anti-B7-H4 / VTCN1 Reference Antibody (Millennium patent anti-B7-H4)
Anti-B7-H5 / VISTA Reference Antibody (onvatilimab)
Anti-B7-H6 / NCR3LG1 Reference Antibody (Dartmouth patent anti-B7-H6)
Anti-BACE1 Reference Antibody (Genentech anti-BACE1)
Anti-Bcl-2 Reference Antibody (U.Toronto patent anti-Bax)
Anti-BST2 / CD317 Reference Antibody (SBI Biotech patent anti-BST2)
Anti-BTLA / CD272 Reference Antibody (icatolimab)
Anti-BTN1A1 Reference Antibody (CTX-2026)
Anti-C1q Reference Antibody (ANX005)
Anti-C1s Reference Antibody (sutimlimab)
Anti-CALCA / CGRP Reference Antibody (eptinezumab)
Anti-CALCA / CGRP Reference Antibody (fremanezumab)
Anti-CALCA / CGRP Reference Antibody (galcanezumab)
Anti-CALCRL / CGRPR Reference Antibody (erenumab)
Anti-CAPRIN1 Reference Antibody (Toray patent anti-Caprin-1)
Anti-CB1 / CNR1 Reference Antibody (GFB-024)
Anti-CB1 / CNR1 Reference Antibody (nimacimab)
Anti-CCL2 / MCP1 Reference Antibody (carlumab)
Anti-CCL20 Reference Antibody (GSK3050002)
Anti-CCL5 / RANTES Reference Antibody (NI-0701)
Anti-CCL5 / RANTES Reference Antibody (VLST-002)
Anti-CCN2 / CTGF Reference Antibody (pamrevlumab)
Anti-CCR2 / CD192 Reference Antibody (plozalizumab)
Anti-CCR4 / CD194 Reference Antibody (mogamulizumab)
Anti-CCR7 / CD197 Reference Antibody (R707)
Anti-CD14 Reference Antibody (atibuclimab)
Anti-CD151 Reference Antibody (Pierre Fabre patent anti-CD151)
Anti-CD163 Reference Antibody (OR2805)
Anti-CD19 Reference Antibody (denintuzumab)
Anti-CD19 Reference Antibody (Duke U. patent anti-CD19)
Anti-CD19 Reference Antibody (Immunomedics hA19)
Anti-CD19 Reference Antibody (inebilizumab)
Anti-CD19 Reference Antibody (obexelimab)
Anti-CD2 Reference Antibody (siplizumab)
Anti-CD20 Reference Antibody (divozilimab)
Anti-CD20 Reference Antibody (ibritumomab)
Anti-CD20 Reference Antibody (obinutuzumab)
Anti-CD20 Reference Antibody (ocaratuzumab)
Anti-CD20 Reference Antibody (ocrelizumab)
Anti-CD20 Reference Antibody (ofatumumab)
Anti-CD20 Reference Antibody (Regeneron patent anti-CD20)
Anti-CD20 Reference Antibody (ripertamab)
Anti-CD20 Reference Antibody (rituximab)
Anti-CD20 Reference Antibody (TRU-015)
Anti-CD20 Reference Antibody (ublituximab)
Anti-CD20 Reference Antibody (veltuzumab)
Anti-CD20 Reference Antibody (zuberitamab)
Anti-CD28 Reference Antibody (FR104)
Anti-CD28L / CD80 Reference Antibody (galiximab)
Anti-CD3 Reference Antibody (otelixizumab)
Anti-CD3 Reference Antibody (visilizumab)
Anti-CD38 Reference Antibody (daratumumab)
Anti-CD38 Reference Antibody (felzartamab)
Anti-CD38 Reference Antibody (isatuximab)
Anti-CD38 Reference Antibody (mezagitamab)
Anti-CD3e Reference Antibody (foralumab)
Anti-CD3e Reference Antibody (teplizumab)
Anti-CD4 Reference Antibody (ibalizumab)
Anti-CD4 Reference Antibody (tregalizumab)
Anti-CD4 Reference Antibody (TRX1)
Anti-CD44v6 Reference Antibody (bivatuzumab)
Anti-CD46 Reference Antibody (FOR46)
Anti-CD47 Reference Antibody (CC-90002)
Anti-CD47 Reference Antibody (lemzoparlimab)
Anti-CD47 Reference Antibody (letaplimab)
Anti-CD47 Reference Antibody (ligufalimab)
Anti-CD47 Reference Antibody (urabrelimab)
Anti-CD48 Reference Antibody (Regeneron patent anti-CD48)
Anti-CD5 Reference Antibody (Magenta patent anti-CD5)
Anti-CD52 Reference Antibody (alemtuzumab)
Anti-CD47 Reference Antibody (magrolimab)
Anti-CD34 Reference Antibody (ITRI patent anti-CD34)
Anti-CD200 Reference Antibody (samalizumab)
Anti-CD19 Reference Antibody (tafasitamab)
Anti-CD19 Reference Antibody (coltuximab)
Anti-CCR5 / CD195 Reference Antibody (leronlimab)
Anti-CA9 / Carbonic anhydrase 9 Reference Antibody (girentuximab)
Anti-BST2 / CD317 Reference Antibody (XmAb 5592)
Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (manelimab)
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
Copyright 2007© ChemicalBook. All rights reserved.